| Product Code: ETC13149205 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Neuropathic Pain Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Neuropathic Pain Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Neuropathic Pain Market Revenues & Volume, 2021 & 2031F |
3.3 North America Neuropathic Pain Market - Industry Life Cycle |
3.4 North America Neuropathic Pain Market - Porter's Five Forces |
3.5 North America Neuropathic Pain Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Neuropathic Pain Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 North America Neuropathic Pain Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.8 North America Neuropathic Pain Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.9 North America Neuropathic Pain Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.10 North America Neuropathic Pain Market Revenues & Volume Share, By Modality, 2021 & 2031F |
3.11 North America Neuropathic Pain Market Revenues & Volume Share, By Mode of Purchase, 2021 & 2031F |
3.12 North America Neuropathic Pain Market Revenues & Volume Share, By Pain Type, 2021 & 2031F |
3.12 North America Neuropathic Pain Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 North America Neuropathic Pain Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Neuropathic Pain Market Trends |
6 North America Neuropathic Pain Market, 2021 - 2031 |
6.1 North America Neuropathic Pain Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Neuropathic Pain Market, Revenues & Volume, By Spinal Cord Stimulation (SCS) Devices, 2021 - 2031 |
6.1.3 North America Neuropathic Pain Market, Revenues & Volume, By External Peripheral Nerve Stimulation, 2021 - 2031 |
6.1.4 North America Neuropathic Pain Market, Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation (Tens) Devices, 2021 - 2031 |
6.2 North America Neuropathic Pain Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Neuropathic Pain Market, Revenues & Volume, By Rechargeable and Non-Rechargeable, 2021 - 2031 |
6.3 North America Neuropathic Pain Market, Revenues & Volume, By Procedure, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Neuropathic Pain Market, Revenues & Volume, By Invasive and Non-Invasive, 2021 - 2031 |
6.4 North America Neuropathic Pain Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 North America Neuropathic Pain Market, Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation, 2021 - 2031 |
6.4.3 North America Neuropathic Pain Market, Revenues & Volume, By Transcranial Magnetic Stimulation, 2021 - 2031 |
6.4.4 North America Neuropathic Pain Market, Revenues & Volume, By Respiratory Electrical Stimulation, 2021 - 2031 |
6.5 North America Neuropathic Pain Market, Revenues & Volume, By Modality, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 North America Neuropathic Pain Market, Revenues & Volume, By Stationary, 2021 - 2031 |
6.5.3 North America Neuropathic Pain Market, Revenues & Volume, By Portable, 2021 - 2031 |
6.6 North America Neuropathic Pain Market, Revenues & Volume, By Mode of Purchase, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 North America Neuropathic Pain Market, Revenues & Volume, By Over-the-Counter Devices, 2021 - 2031 |
6.6.3 North America Neuropathic Pain Market, Revenues & Volume, By Prescription-Based Devices, 2021 - 2031 |
6.7 North America Neuropathic Pain Market, Revenues & Volume, By Pain Type, 2021 - 2031 |
6.7.1 Overview & Analysis |
6.7.2 North America Neuropathic Pain Market, Revenues & Volume, By Peripheral Neuropathy, 2021 - 2031 |
6.7.3 North America Neuropathic Pain Market, Revenues & Volume, By Entrapment Neuropathy, 2021 - 2031 |
6.7.4 North America Neuropathic Pain Market, Revenues & Volume, By Phantom Limb Neuropathy, 2021 - 2031 |
6.7.5 North America Neuropathic Pain Market, Revenues & Volume, By Trigeminal Neuralgia, 2021 - 2031 |
6.7.6 North America Neuropathic Pain Market, Revenues & Volume, By Post Herpetic Neuralgia (PHN), 2021 - 2031 |
6.7.7 North America Neuropathic Pain Market, Revenues & Volume, By Post Traumatic Neuropathy, 2021 - 2031 |
6.7.8 North America Neuropathic Pain Market, Revenues & Volume, By Foot Pain, 2021 - 2031 |
6.7.9 North America Neuropathic Pain Market, Revenues & Volume, By Coccydynia, 2021 - 2031 |
6.8 North America Neuropathic Pain Market, Revenues & Volume, By Indication, 2021 - 2031 |
6.8.1 Overview & Analysis |
6.8.2 North America Neuropathic Pain Market, Revenues & Volume, By Spinal Stenosis, 2021 - 2031 |
6.8.3 North America Neuropathic Pain Market, Revenues & Volume, By Chemotherapy-Induced Peripheral Neuropathy, 2021 - 2031 |
6.8.4 North America Neuropathic Pain Market, Revenues & Volume, By Diabetic Neuropathy, 2021 - 2031 |
6.8.5 North America Neuropathic Pain Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Neuropathic Pain Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Neuropathic Pain Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.1 United States (US) Neuropathic Pain Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.2 Canada Neuropathic Pain Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.3 Rest of North America Neuropathic Pain Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3 North America Neuropathic Pain Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
7.3.1 United States (US) Neuropathic Pain Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.3.2 Canada Neuropathic Pain Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.3.3 Rest of North America Neuropathic Pain Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.4 North America Neuropathic Pain Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.4.1 United States (US) Neuropathic Pain Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.4.2 Canada Neuropathic Pain Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.4.3 Rest of North America Neuropathic Pain Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.5 North America Neuropathic Pain Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.1 United States (US) Neuropathic Pain Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.2 Canada Neuropathic Pain Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.3 Rest of North America Neuropathic Pain Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6 North America Neuropathic Pain Market, Revenues & Volume, By Modality, 2021 - 2031 |
7.6.1 United States (US) Neuropathic Pain Market, Revenues & Volume, By Modality, 2021 - 2031 |
7.6.2 Canada Neuropathic Pain Market, Revenues & Volume, By Modality, 2021 - 2031 |
7.6.3 Rest of North America Neuropathic Pain Market, Revenues & Volume, By Modality, 2021 - 2031 |
7.7 North America Neuropathic Pain Market, Revenues & Volume, By Mode of Purchase, 2021 - 2031 |
7.7.1 United States (US) Neuropathic Pain Market, Revenues & Volume, By Mode of Purchase, 2021 - 2031 |
7.7.2 Canada Neuropathic Pain Market, Revenues & Volume, By Mode of Purchase, 2021 - 2031 |
7.7.3 Rest of North America Neuropathic Pain Market, Revenues & Volume, By Mode of Purchase, 2021 - 2031 |
7.8 North America Neuropathic Pain Market, Revenues & Volume, By Pain Type, 2021 - 2031 |
7.8.1 United States (US) Neuropathic Pain Market, Revenues & Volume, By Pain Type, 2021 - 2031 |
7.8.2 Canada Neuropathic Pain Market, Revenues & Volume, By Pain Type, 2021 - 2031 |
7.8.3 Rest of North America Neuropathic Pain Market, Revenues & Volume, By Pain Type, 2021 - 2031 |
7.9 North America Neuropathic Pain Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.9.1 United States (US) Neuropathic Pain Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.9.2 Canada Neuropathic Pain Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.9.3 Rest of North America Neuropathic Pain Market, Revenues & Volume, By Indication, 2021 - 2031 |
8 North America Neuropathic Pain Market Key Performance Indicators |
9 North America Neuropathic Pain Market - Export/Import By Countries Assessment |
10 North America Neuropathic Pain Market - Opportunity Assessment |
10.1 North America Neuropathic Pain Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Neuropathic Pain Market Opportunity Assessment, By Type, 2021 & 2031F |
10.3 North America Neuropathic Pain Market Opportunity Assessment, By Product Type, 2021 & 2031F |
10.4 North America Neuropathic Pain Market Opportunity Assessment, By Procedure, 2021 & 2031F |
10.5 North America Neuropathic Pain Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.6 North America Neuropathic Pain Market Opportunity Assessment, By Modality, 2021 & 2031F |
10.7 North America Neuropathic Pain Market Opportunity Assessment, By Mode of Purchase, 2021 & 2031F |
10.8 North America Neuropathic Pain Market Opportunity Assessment, By Pain Type, 2021 & 2031F |
10.9 North America Neuropathic Pain Market Opportunity Assessment, By Indication, 2021 & 2031F |
11 North America Neuropathic Pain Market - Competitive Landscape |
11.1 North America Neuropathic Pain Market Revenue Share, By Companies, 2022 |
11.2 North America Neuropathic Pain Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here